fda tirzepatide shortage resolved 2025 is semaglutide on the list As of February 21, 2025, updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” FDA sets tirzepatide compounding deadlines

Users should mark the pen with the date of first use to keep track of this timeline

The peptide world has been racing toward dual and triple agonism (e.g

Having people who understand your journey, whether family, friends, or an online community, makes a meaningful difference in long-term success

Two genes involved in gut hormones that influence appetite and digestion may be a factor in how people respond to weight loss drugs, according to a recent US study

Some users who switch from semaglutide to tirzepatide report less bloating but more nausea, while others experience the opposite pattern

We conclude that retatrutide excites the beating rate in RA via GCGR, signalling via cAMP and PKA